Form 8-K - Current report:
SEC Accession No. 0001213900-24-099649
Filing Date
2024-11-18
Accepted
2024-11-18 16:15:09
Documents
18
Period of Report
2024-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0221547-8k_citius.htm   iXBRL 8-K 44442
2 FORM OF INVESTOR WARRANT ISSUED ON NOVEMBER 18, 2024 ea022154701ex4-1_citius.htm EX-4.1 96886
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea022154701ex5-1_citius.htm EX-5.1 10203
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF NOVEMBER 15, 2024, BY AND AMO ea022154701ex10-1_citius.htm EX-10.1 211326
5 PRESS RELEASE, DATED NOVEMBER 15, 2024 ea022154701ex99-1_citius.htm EX-99.1 11773
6 PRESS RELEASE, DATED NOVEMBER 18, 2024. ea022154701ex99-2_citius.htm EX-99.2 10213
  Complete submission text file 0001213900-24-099649.txt   654391

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ctxr-20241115.xsd EX-101.SCH 3027
8 XBRL LABEL FILE ctxr-20241115_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE ctxr-20241115_pre.xml EX-101.PRE 22367
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0221547-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 241471672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)